首页 | 本学科首页   官方微博 | 高级检索  
     


Combined use of high-sensitivity C-reactive protein and apolipoprotein B/apolipoprotein A-1 ratio prior to elective coronary angiography and oral glucose tolerance tests
Authors:Wen Zhu-zhi  Geng Deng-feng  Luo Jin-gang  Wang Jing-feng
Affiliation:aDepartment of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China;bDepartment of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
Abstract:

Objectives

The study aimed to investigate the predictive value of the combination of high-sensitivity C-reactive protein (hs-CRP) and apolipoprotein B (apoB)/apoA-1 ratio for the outcomes of coronary angiography (CAG), echocardiography and oral glucose tolerance tests (OGTTs).

Design and methods

Hs-CRP, apoB, apoA-1, and the profiles of CAG, echocardiography and OGTTs as well as traditional risk factors were measured in 1757 cardiology patients.

Results

Hs-CRP or apoB/apoA-1 ratio was significantly correlated with the presence and severity of angiographic profiles, the levels of left ventricular (LV) ejection fraction, LV mass and LV mass index, and the presence of abnormal glucose metabolism. The combination of hs-CRP and apoB/apoA-1 ratio had greater correlation with abnormal glucose metabolism than its individual components in patients with normal fasting glucose, and was an independent predictor for coronary artery disease.

Conclusions

The combination of hs-CRP and apoB/apoA-1 ratio may be a strong predictor for coronary artery disease and abnormal glucose metabolism.
Keywords:Abbreviations: CAG, coronary angiography   CAD, coronary artery disease   OGTT, oral glucose tolerance test   DM, diabetes mellitus   MI, myocardial infarction   hs-CRP, high-sensitivity C-reactive protein   apoB/apoA-1, apolipoprotein B/apolipoprotein A-1   LV, left ventricular   CVD, cardiovascular disease   AGM, abnormal glucose metabolism   CHF, congestive heart failure   LVEDD, left ventricular end-diastolic diameter   PWT, posterior wall thickness   IVST, interventricular septum thickness   LVM, left ventricular mass   LVMI, left ventricular mass index   BSA, body surface area   LVH, left ventricular hypertrophy   EF, ejection fraction   FPG, fasting plasma glucose   2-h PG, 2-hour plasma glucose   IFG, impaired fasting glucose   IGT, impaired glucose tolerance   TC, total cholesterol   HDL-C, high-density lipoprotein cholesterol   LDL-C, low-density lipoprotein cholesterol   TG, triglycerides   BMI, body mass index   ROC, receiver operating characteristics
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号